Doximity, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $644.9M | $570.4M | $475.4M | $419.1M | $343.5M | $206.9M | $116.4M |
| Cost of Revenue | $70.3M | $55.9M | $50.7M | $53.5M | $39.8M | $31.2M | $14.9M |
| Gross Profit | $574.5M | $514.5M | $424.8M | $365.6M | $303.8M | $175.7M | $101.5M |
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | 84.9% | 87.2% |
| Operating Expenses | |||||||
| Research & Development | $130.7M | $93.0M | $82.0M | $80.2M | $62.4M | $43.9M | $32.4M |
| SG&A Expense | $65.3M | $45.7M | $37.8M | $36.7M | $35.7M | $16.5M | $7.4M |
| Operating Income | $214.9M | $227.8M | $163.9M | $125.1M | $113.5M | $53.3M | $22.2M |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.0% | 25.8% | 19.0% |
| Interest Expense | — | — | — | — | — | — | — |
| Pretax Income | $250.0M | $263.6M | $185.2M | $133.2M | $114.0M | $57.8M | $23.5M |
| Income Tax Expense | $54.0M | $40.4M | $37.6M | $20.3M | $-40.8M | $7.6M | $-6.2M |
| Net Income | $196.1M | $223.2M | $147.6M | $112.8M | $154.8M | $50.2M | $29.7M |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | 24.3% | 25.5% |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.15 | $0.08 |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.12 | $0.07 |
| Shares Outstanding (Basic) | 187.0M | 186.8M | 190.2M | 193.2M | 163.5M | 148.7M | 133.5M |
| Shares Outstanding (Diluted) | 199.0M | 201.2M | 205.7M | 213.4M | 191.0M | 190.3M | 163.4M |
| Dividends Per Share | — | — | — | — | — | — | — |